Abstract
Objective
Aneurysm treatment with endovascular coiling is associated with a better outcome than neurosurgical clipping in patients with subarachnoid haemorrhage (SAH). The better outcome after coiling may decrease the risk reduction from other treatments in these patients, and thus may increase sample sizes for current or future neuroprotective trials. The influence of the method of aneurysm treatment was studied in our randomised MASH trial, which assessed in a factorial design the efficacy of magnesium and aspirin in preventing delayed cerebral ischaemia (DCI) and poor outcome.
Methods
Between November 2000 and January 2004 315 patients were enrolled in the trial; 55 of them had no aneurysm treatment and were excluded for the current analysis, 176 underwent neurosurgical and 84 endovascular treatment. The effect of treatment on the risk of DCI was assessed by means of Cox proportional hazards modelling and that of poor outcome by means of logistic regression analysis.
Results
The hazard ratio of DCI with aspirin was 1.4 (95 % CI 0.3 – 1.7) after coiling and 1.9 (0.8 – 4.4) after clipping, and with magnesium 0.4 (0.1 – 1.2) after coiling and 0.8 (0.4 – 1.7) after clipping. The odds ratio of poor outcome with aspirin was 0.7 (0.2 – 2.9) after coiling and 0.8 (0.3 – 2.3) after clipping, and with magnesium 0.3 (0.1 – 1.0) after coiling and 0.8 (0.4 – 1.6) after clipping.
Conclusion
This post hoc analysis does not suggest that medical treatments are less effective after endovascular than after neurosurgical treatment in patients with SAH, and thus do not support a need for adjusting sample size calculations in future trials.
Similar content being viewed by others
References
Cox DR (1972) Regression models and life-tables. Journal of the Royal Statistical Society, Series B 34:187–220
Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev CD000277
Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ (2007) Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev CD006184
Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ (2008) Magnesium in Aneurysmal Subarachnoid Hemorrhage (MASH II), a phase III clinical trial. J Int Stroke 3:63–65
Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R (2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360:1267–1274
van den Bergh WM (2007) Response to Letter by Chan et al. Author’s reply. Stroke 38:e15
van den Bergh WM, Algra A, Dorhout Mees SM, van Kooten F., Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ (2006) Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study. Stroke 37:2326–2330
van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ (2005) Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 36:1011–1015
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Magnesium and Acetylsalicylic acid in Subarachnoid Haemorrhage (MASH) Study Group:
W. M. van den Bergh,A. Algra, S. M. Dorhout Mees,J. van Gijn,G. J. E. Rinkel,Dept. of Neurology,University Medical Centre Utrecht,Utrecht, The Netherlands
Ale Algra,Julius Centre for Health Sciences and Primary Care,University Medical Centre Utrecht,Utrecht, The Netherlands
Fop van Kooten,Dept. of Neurology,Erasmus Medical Centre,Rotterdam, The Netherlands
Clemens M.F. Dirven,Dept. of Neurology,VU University Medical Centre,Amsterdam, The Netherlands
Marinus Vermeulen,Dept. of Neurology,Academic Medical CentreUniversity of Amsterdam,Amsterdam, The Netherlands
W. M. van den Bergh, MD, PhD ✉, Dept. of Intensive Care, Room Q04.460,University Medical Centre Utrecht,P.O. Box 85500,3508 GA, Utrecht, The Netherlands,Tel.: +31-30/2508350,Fax: +31-30/2522782,E-Mail: w.m.vandenbergh@umcutrecht.nl
Rights and permissions
About this article
Cite this article
van den Bergh, W.M., Algra, A., Rinkel, G.J.E. et al. Magnesium and aspirin treatment in patients with subarachnoid haemorrhage. J Neurol 256, 213–216 (2009). https://doi.org/10.1007/s00415-009-0057-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-0057-5